CDRH Review Of Expanded Imaging Agent Indications Urged By NEMA
This article was originally published in The Gray Sheet
Executive Summary
CDRH should serve as the lead reviewer for premarket applications of already-approved contrast agents indicated for use with diagnostic imaging devices, according to Philips Medical Systems VP-Quality & Regulatory Affairs Terry Sweeney